Cytovale
South San Francisco, California, United States
Cytovale is a healthcare startup focused on improving sepsis detection through its innovative diagnostic tool, IntelliSep. This FDA-cleared in vitro diagnostic test utilizes advanced technology to risk-stratify patients based on their likelihood of developing sepsis within three days following testing. IntelliSep takes around 8 minutes to provide results, significantly enhancing the speed and accuracy of sepsis diagnosis in emergency healthcare settings. By analyzing the immune response and biomechanical properties of white blood cells, Cytovale aims to deliver clear and actionable results, ultimately improving patient outcomes and operational efficiencies in hospitals.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2012
- Website
- cytovale.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Cytovale?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now